INBX
Inhibrx Biosciences, Inc.
Company overview
- Market capitalization
- $1.50B
- Employees
- 109
- Latest publication
- 2026-09-29
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 1,300,000USD | 0USD | 100,000USD | 0USD |
| Research Development | 23,899,000USD | 24,687,000USD | 25,349,000USD | 28,535,000USD | 22,267,000USD | 36,877,000USD | 33,367,000USD | 38,233,000USD |
| Selling General Administrative | 8,250,000USD | 5,710,000USD | 5,574,000USD | 5,277,000USD | 6,422,000USD | 6,024,000USD | 16,661,000USD | 7,904,000USD |
| General And Administrative Expenses | 8,250,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 32,149,000USD | 30,390,000USD | 30,359,000USD | 33,812,000USD | 28,027,000USD | 42,226,000USD | 49,339,000USD | 46,037,000USD |
| Operating Income | -32,149,000USD | -30,927,000USD | -30,923,000USD | -33,812,000USD | -27,389,000USD | -42,901,000USD | -49,928,000USD | -46,797,000USD |
| Total Other Income Expense Net | -4,498,000USD | -2,514,000USD | -1,911,000USD | -1,444,000USD | -1,263,000USD | -410,000USD | 2,063,000USD | 2,933,000USD |
| Interest Expense | 5,693,000USD | 3,509,000USD | 3,185,000USD | 3,181,000USD | 3,141,000USD | 2,689,000USD | 0USD | 0USD |
| Income Before Tax | -36,647,000USD | -33,441,000USD | -32,834,000USD | -35,256,000USD | -28,652,000USD | -43,311,000USD | -47,865,000USD | -43,864,000USD |
| Income Tax Expense | 3,000USD | — | — | — | 2,000USD | — | — | — |
| Net Income | -36,650,000USD | -33,441,000USD | -32,834,000USD | -35,256,000USD | -28,654,000USD | -43,311,000USD | -47,865,000USD | -43,864,000USD |
| Cost Of Revenue | — | 537,000USD | 564,000USD | 582,000USD | 662,000USD | 675,000USD | 689,000USD | 760,000USD |
| Gross Profit | — | -537,000USD | -564,000USD | -582,000USD | 638,000USD | -675,000USD | -589,000USD | -760,000USD |
| Interest Income | — | 1,007,000USD | 1,313,000USD | 1,783,000USD | 2,124,000USD | 2,329,000USD | 2,003,000USD | 2,892,000USD |
| Net Interest Income | — | -2,502,000USD | -1,872,000USD | -1,398,000USD | -1,017,000USD | -360,000USD | 2,003,000USD | 2,892,000USD |
| Tax Provision | — | 0USD | 0USD | 0USD | 2,000USD | 0USD | 0USD | 0USD |
| Net Income From Continuing Ops | — | -33,441,000USD | -32,834,000USD | -35,256,000USD | -28,654,000USD | -43,311,000USD | -47,865,000USD | -43,864,000USD |
| Ebit | — | -30,927,000USD | -30,923,000USD | -32,075,000USD | -25,511,000USD | -40,622,000USD | -47,865,000USD | -43,864,000USD |
| Ebitda | — | -30,390,000USD | -30,359,000USD | -31,492,000USD | -24,850,000USD | -39,947,000USD | -47,176,000USD | -43,104,000USD |
| Depreciation And Amortization | — | 537,000USD | 564,000USD | 583,000USD | 661,000USD | 675,000USD | 689,000USD | 760,000USD |
| Reconciled Depreciation | — | 537,000USD | 564,000USD | 583,000USD | 661,000USD | 675,000USD | 689,000USD | 760,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,300,000USD | 200,000USD | 1,800,000USD | 2,192,000USD | 7,125,000USD | 12,808,000USD | 9,093,000USD | 7,500,000USD |
| Cost Of Revenue | 2,483,000USD | 2,285,000USD | 1,191,000USD | 110,186,000USD | 2,688,000USD | 73,495,000USD | 47,907,000USD | 33,454,000USD |
| Gross Profit | -1,183,000USD | -2,085,000USD | 609,000USD | -107,994,000USD | 4,437,000USD | -60,687,000USD | -38,814,000USD | -25,954,000USD |
| Research Development | 113,028,000USD | 203,743,000USD | 190,648,000USD | 110,186,000USD | 71,440,000USD | 73,495,000USD | 47,907,000USD | 33,454,000USD |
| Selling General Administrative | 23,297,000USD | 127,905,000USD | 29,381,000USD | 21,123,000USD | 12,355,000USD | 6,836,000USD | 9,018,000USD | 4,654,000USD |
| Unclassified Operating Expenses | -2,483,000USD | — | — | -110,187,000USD | -71,454,000USD | — | -4,118,000USD | -1,095,000USD |
| Total Operating Expenses | 133,842,000USD | 329,363,000USD | 219,830,000USD | 21,122,000USD | 12,341,000USD | 80,251,000USD | 52,807,000USD | 37,013,000USD |
| Operating Income | -135,025,000USD | -331,448,000USD | -219,221,000USD | -129,117,000USD | -76,564,000USD | -67,443,000USD | -43,714,000USD | -29,513,000USD |
| Interest Income | 7,549,000USD | 10,940,000USD | 11,917,000USD | — | — | — | — | — |
| Interest Expense | 12,196,000USD | 13,491,000USD | 31,840,000USD | 16,107,000USD | 5,216,000USD | 10,816,000USD | 5,719,000USD | 1,480,000USD |
| Net Interest Income | -4,647,000USD | -2,551,000USD | -19,923,000USD | — | — | — | — | — |
| Income Before Tax | -140,053,000USD | 1,687,574,000USD | -239,724,000USD | -145,223,000USD | -81,766,000USD | -75,634,000USD | -50,502,000USD | -30,925,000USD |
| Income Tax Expense | 2,000USD | 2,000USD | 3,000USD | 3,000USD | 2,000USD | 3,000USD | 898,000USD | 96,000USD |
| Tax Provision | 2,000USD | 2,000USD | 3,000USD | 3,000USD | — | — | — | — |
| Net Income | -140,055,000USD | 1,687,572,000USD | -241,361,000USD | -145,226,000USD | -81,768,000USD | -75,637,000USD | -51,400,000USD | -31,163,000USD |
| Net Income From Continuing Ops | -140,055,000USD | 1,687,572,000USD | -241,361,000USD | -115,325,000USD | — | — | — | — |
| Ebit | -135,025,000USD | 1,701,065,000USD | -207,884,000USD | -127,042,000USD | -76,564,000USD | -64,818,000USD | -45,122,000USD | -29,445,000USD |
| Ebitda | -132,542,000USD | 1,703,350,000USD | -206,693,000USD | -125,817,000USD | -75,369,000USD | -63,799,000USD | -42,604,000USD | -28,769,000USD |
| Depreciation And Amortization | 2,483,000USD | 2,285,000USD | 1,191,000USD | 1,225,000USD | 1,195,000USD | 1,019,000USD | 2,518,000USD | 676,000USD |
| Reconciled Depreciation | 2,483,000USD | 2,285,000USD | 1,191,000USD | 1,225,000USD | — | — | — | — |
| Total Other Income Expense Net | -5,028,000USD | 2,019,022,000USD | -20,503,000USD | -16,106,000USD | -5,202,000USD | -8,191,000USD | -6,788,000USD | -1,412,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 154,222,000USD | 183,967,000USD | 146,478,000USD | 177,471,000USD | 212,118,000USD | 242,639,000USD | 180,767,000USD | 222,562,000USD |
| Cash And Equivalents | 133,344,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 142,212,000USD | 171,341,000USD | 132,832,000USD | 161,423,000USD | 193,964,000USD | 223,386,000USD | 160,398,000USD | 207,446,000USD |
| Other Current Assets | 574,000USD | 9,498,000USD | 8,434,999USD | 7,498,000USD | 6,430,000USD | 6,652,000USD | 7,382,000USD | 9,987,000USD |
| Other Non Current Assets | 4,769,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 207,199,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 28,064,000USD | 26,512,000USD | 33,799,000USD | 35,983,000USD | 38,939,000USD | 43,639,000USD | 40,730,000USD | 44,095,000USD |
| Other Current Liabilities | 15,773,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -52,977,000USD | -21,035,000USD | 7,993,000USD | 36,830,000USD | 68,559,000USD | 94,443,000USD | 133,584,000USD | 178,467,000USD |
| Total Equity Including Noncontrolling Interest | -52,977,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 176,285,000USD | 174,994,000USD | 100,559,000USD | 99,917,000USD | 99,279,000USD | 98,653,000USD | — | — |
| Property Plant Equipment Net | 7,241,000USD | 8,248,000USD | 9,268,000USD | 10,310,000USD | 11,345,000USD | 12,450,000USD | 13,538,000USD | 8,404,000USD |
| Accounts Payable | 9,800,000USD | 8,762,000USD | 5,944,000USD | 6,773,000USD | 8,292,000USD | 8,892,000USD | 9,245,000USD | 12,370,000USD |
| Short Term Debt | 2,491,000USD | 2,408,000USD | 2,326,000USD | 2,247,000USD | 2,169,000USD | 1,973,000USD | 1,595,000USD | 1,835,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -316,278,000USD | -279,628,000USD | -246,187,000USD | -213,353,000USD | -178,097,000USD | -149,443,000USD | -106,132,000USD | -58,267,000USD |
| Total Liab | — | 205,002,000USD | 138,485,000USD | 140,641,000USD | 143,559,000USD | 148,196,000USD | 47,183,000USD | 44,095,000USD |
| Other Current Liab | — | 15,342,000USD | 25,529,000USD | 26,963,000USD | 28,478,000USD | 32,774,000USD | 29,890,000USD | 29,890,000USD |
| Capital Stock | — | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Cash | — | 161,657,000USD | 124,220,000USD | 153,088,000USD | 186,567,000USD | 216,520,000USD | 152,596,000USD | 196,332,000USD |
| Cash And Short Term Investments | — | 161,657,000USD | 124,220,000USD | 153,088,000USD | 186,567,000USD | 216,520,000USD | 152,596,000USD | 196,332,000USD |
| Net Debt | — | -155,753,000USD | -17,208,000USD | -146,100,000USD | -79,778,000USD | -109,990,000USD | -144,548,000USD | -194,497,000USD |
| Short Long Term Debt Total | — | 5,904,000USD | 107,012,000USD | 6,988,000USD | 106,789,000USD | 106,530,000USD | 8,048,000USD | 1,835,000USD |
| Net Receivables | — | 186,000USD | 177,000USD | 837,000USD | 967,000USD | 214,000USD | 420,000USD | 1,127,000USD |
| Property Plant Equipment Gross | — | 19,906,000USD | 20,389,000USD | 20,885,000USD | 21,574,000USD | 22,018,000USD | 22,431,000USD | 16,620,000USD |
| Common Stock Shares Outstanding | — | 15,585,000shares | 15,487,000shares | 15,478,000shares | 15,468,000shares | 15,468,000shares | 14,475,904shares | 15,468,000shares |
| Non Current Assets Total | — | 12,626,000USD | 13,646,000USD | 16,048,000USD | 18,154,000USD | 19,253,000USD | 20,369,000USD | 15,116,000USD |
| Non Current Liabilities Total | — | 178,490,000USD | 104,686,000USD | 104,658,000USD | 104,620,000USD | 104,557,000USD | 6,453,000USD | 0USD |
| Non Currrent Assets Other | — | 4,378,000USD | 4,378,000USD | 5,738,000USD | 6,809,000USD | 6,803,000USD | 6,831,000USD | 6,712,000USD |
| Net Working Capital | — | 144,829,000USD | 99,033,000USD | 125,440,000USD | 155,025,000USD | 179,747,000USD | 119,668,000USD | 163,351,000USD |
| Unclassified Non Current Liabilities | — | 3,496,000USD | 4,127,000USD | 4,741,000USD | 5,341,000USD | 5,904,000USD | 6,453,000USD | — |
| Unclassified Equity | — | 258,591,000USD | 254,178,000USD | 250,181,000USD | 246,654,000USD | 243,884,000USD | 239,714,000USD | 236,732,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 146,478,000USD | 180,767,000USD | 307,893,000USD | 290,875,000USD | 150,450,000USD | 143,740,000USD | 26,489,000USD | 9,984,000USD |
| Other Current Assets | 8,434,999USD | 7,382,000USD | 16,656,000USD | 6,371,000USD | 7,811,000USD | 132,172,000USD | 376,000USD | 553,000USD |
| Total Liab | 138,485,000USD | 47,183,000USD | 264,390,000USD | 232,818,000USD | 98,067,000USD | 68,267,000USD | 120,058,000USD | 67,627,000USD |
| Total Stockholder Equity | 7,993,000USD | 133,584,000USD | 43,503,000USD | 58,057,000USD | 52,383,000USD | 75,473,000USD | -93,569,000USD | -57,643,000USD |
| Other Current Liab | 25,529,000USD | 29,890,000USD | 43,295,000USD | 17,224,000USD | 9,621,000USD | 13,357,000USD | 4,848,000USD | 2,090,000USD |
| Common Stock | 1,000USD | 1,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 2,000USD | 3,000USD |
| Capital Stock | 1,000USD | 1,000USD | 5,000USD | — | — | — | — | — |
| Retained Earnings | -246,187,000USD | -106,132,000USD | -613,734,000USD | -372,373,000USD | -227,147,000USD | -145,379,000USD | -69,255,000USD | -17,855,000USD |
| Cash | 124,220,000USD | 152,596,000USD | 277,924,000USD | 273,865,000USD | 131,301,000USD | 128,664,000USD | 11,540,000USD | 2,103,000USD |
| Cash And Short Term Investments | 124,220,000USD | 152,596,000USD | 277,924,000USD | 273,865,000USD | 131,301,000USD | 128,664,000USD | 11,540,000USD | 2,103,000USD |
| Total Current Assets | 132,832,000USD | 160,398,000USD | 295,358,000USD | 280,493,000USD | 139,112,000USD | 132,172,000USD | 15,561,000USD | 5,657,000USD |
| Total Current Liabilities | 33,799,000USD | 40,730,000USD | 56,312,000USD | 27,576,000USD | 22,454,000USD | 31,399,000USD | 20,570,000USD | 16,182,000USD |
| Net Debt | -17,208,000USD | -144,548,000USD | -67,783,000USD | -66,763,000USD | -59,156,999USD | -91,210,000USD | 30,193,000USD | 7,391,000USD |
| Short Term Debt | 2,326,000USD | 1,595,000USD | 2,063,000USD | 1,860,000USD | 1,674,000USD | 1,503,000USD | 4,668,000USD | 5,931,000USD |
| Short Long Term Debt Total | 107,012,000USD | 8,048,000USD | 210,141,000USD | 207,102,000USD | 72,144,000USD | 37,454,000USD | 41,733,000USD | 9,494,000USD |
| Long Term Debt | 100,559,000USD | — | 206,968,000USD | — | — | — | — | — |
| Net Receivables | 177,000USD | 420,000USD | 778,000USD | 257,000USD | 878,000USD | 615,000USD | 438,000USD | 690,000USD |
| Accounts Payable | 5,944,000USD | 9,245,000USD | 10,954,000USD | 8,326,000USD | 9,125,000USD | 13,458,000USD | 3,115,000USD | 6,530,000USD |
| Property Plant Equipment Net | 9,268,000USD | 13,538,000USD | 9,371,000USD | 7,218,000USD | 9,491,000USD | 11,323,000USD | 10,683,000USD | 2,593,000USD |
| Property Plant Equipment Gross | 20,389,000USD | 22,431,000USD | 16,058,000USD | 12,758,000USD | — | — | — | — |
| Common Stock Shares Outstanding | 15,487,000shares | 14,475,904shares | 47,130,000shares | 40,108,000shares | 38,010,000shares | 25,261,000shares | 36,554,606shares | 27,077,000shares |
| Non Current Assets Total | 13,646,000USD | 20,369,000USD | 12,535,000USD | 10,382,000USD | 11,338,000USD | 11,568,000USD | 10,928,000USD | 4,327,000USD |
| Non Current Liabilities Total | 104,686,000USD | 6,453,000USD | 208,078,000USD | 205,242,000USD | 75,613,000USD | 36,868,000USD | 99,488,000USD | 51,445,000USD |
| Non Currrent Assets Other | 4,378,000USD | 6,831,000USD | 3,164,000USD | 3,164,000USD | 1,847,000USD | 245,000USD | 245,000USD | 1,734,000USD |
| Net Working Capital | 99,033,000USD | 119,668,000USD | 239,046,000USD | -14,509,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | 4,127,000USD | 6,453,000USD | — | 205,242,000USD | 75,613,000USD | 36,868,000USD | 99,488,000USD | 51,445,000USD |
| Unclassified Equity | 254,178,000USD | 239,714,000USD | 657,227,000USD | 430,426,000USD | 429,976,000USD | 364,588,000USD | 35,191,000USD | -38,086,000USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | — | -150,450,000USD | -143,740,000USD | -59,507,000USD | -1,705,000USD |
| Current Deferred Revenue | — | — | — | 166,000USD | 2,034,000USD | 3,081,000USD | 7,939,000USD | 1,631,000USD |
| Inventory | — | — | — | -257,000USD | -878,000USD | -129,279,000USD | 3,207,000USD | 2,311,000USD |
| Unclassified Current Assets | — | — | — | — | — | -129,279,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 1,060,000USD |
| Stock Based Compensation | 5,757,000USD |
| Change To Account Receivables | 0USD |
| Change To Liabilities | -5,927,000USD |
| Change In Working Capital | 3,137,000USD |
| Operating Cash Flow | -67,943,000USD |
| Capital Expenditures | 0USD |
| Investing Cash Flow | 0USD |
| Financing Cash Flow | 77,067,000USD |
| Change In Cash | 9,124,000USD |
| End Cash Flow | 133,344,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -33,441,000USD | -32,834,000USD | -35,256,000USD | -28,654,000USD | -43,311,000USD | -47,865,000USD | -43,864,000USD | 1,828,574,000USD |
| Depreciation | 537,000USD | 564,000USD | 583,000USD | 661,000USD | 675,000USD | 689,000USD | 760,000USD | 475,000USD |
| Stock Based Compensation | 2,653,000USD | 2,743,000USD | 3,175,000USD | 2,770,000USD | 2,450,000USD | 2,982,000USD | 2,965,000USD | 47,528,000USD |
| Other Non Cash Items | 3,868,000USD | 1,120,000USD | 1,097,000USD | 1,070,000USD | 967,000USD | 470,000USD | 498,000USD | -1,969,426,000USD |
| Change To Account Receivables | -9,000USD | 660,000USD | 130,000USD | -753,000USD | 206,000USD | 707,000USD | 260,000USD | 1,000USD |
| Change In Working Capital | -8,990,000USD | -1,715,000USD | -3,423,000USD | -5,800,000USD | 3,324,000USD | 4,000USD | 9,360,000USD | 35,491,000USD |
| Total Cash From Operating Activities | -38,026,000USD | -30,122,000USD | -33,824,000USD | -29,953,000USD | -35,895,000USD | -43,720,000USD | -30,281,000USD | -57,358,000USD |
| Capital Expenditures | 0USD | 0USD | -10,000USD | 0USD | -21,000USD | -16,000USD | -247,000USD | -1,215,000USD |
| Free Cash Flow | -38,026,000USD | -30,122,000USD | -33,834,000USD | -29,953,000USD | -35,916,000USD | -43,736,000USD | -30,528,000USD | -58,573,000USD |
| Net Borrowings | 74,992,000USD | 0USD | 0USD | 0USD | 99,965,000USD | — | 0USD | — |
| Total Cash From Financing Activities | 75,463,000USD | 1,254,000USD | 352,000USD | 0USD | 99,840,000USD | 0USD | 2,705,000USD | 32,950,000USD |
| Change In Cash | 37,437,000USD | -28,868,000USD | -33,479,000USD | -29,953,000USD | 63,924,000USD | -43,736,000USD | -30,528,000USD | -25,623,000USD |
| Begin Period Cash Flow | 124,220,000USD | 153,088,000USD | 186,567,000USD | 216,520,000USD | 152,596,000USD | 196,332,000USD | 226,860,000USD | 252,483,000USD |
| End Period Cash Flow | 161,657,000USD | 124,220,000USD | 153,088,000USD | 186,567,000USD | 216,520,000USD | 152,596,000USD | 196,332,000USD | 226,860,000USD |
| Unclassified Operating Cash Flow | -2,653,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | 1,254,000USD | — | — | — | -32,950,000USD | — | 35,655,000USD |
| Investments | — | — | -7,000USD | 0USD | -21,000USD | -16,000USD | -247,000USD | -1,215,000USD |
| Total Cashflows From Investing Activities | — | — | -7,000USD | — | -21,000USD | -16,000USD | -247,000USD | -1,215,000USD |
| Other Cashflows From Investing Activities | — | — | 3,000USD | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | — | 352,000USD | — | -125,000USD | 32,950,000USD | 2,705,000USD | -2,705,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | 1,215,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -140,055,000USD | 1,687,572,000USD | -239,727,000USD | -145,226,000USD | -81,768,000USD | -76,124,000USD | -51,400,000USD | -31,021,000USD |
| Depreciation | 2,483,000USD | 2,285,000USD | 1,191,000USD | 1,225,000USD | 1,195,000USD | 1,019,000USD | 1,163,000USD | 676,000USD |
| Stock Based Compensation | 11,138,000USD | 58,518,000USD | 24,846,000USD | 20,450,000USD | 15,048,000USD | 5,023,000USD | 3,974,000USD | 2,484,000USD |
| Other Non Cash Items | 4,254,000USD | -1,994,835,000USD | 5,033,000USD | 5,088,000USD | 2,727,000USD | 11,563,000USD | 9,614,000USD | 522,000USD |
| Change To Account Receivables | 243,000USD | 381,000USD | -521,000USD | 130,000USD | -167,000USD | 117,000USD | 491,000USD | -550,000USD |
| Change In Working Capital | -7,614,000USD | 52,051,000USD | 15,348,000USD | 3,162,000USD | -17,516,000USD | 12,691,000USD | 3,485,000USD | 4,247,000USD |
| Total Cash From Operating Activities | -129,794,000USD | -194,409,000USD | -193,309,000USD | -115,301,000USD | -80,323,000USD | -47,968,000USD | -32,079,000USD | -23,092,000USD |
| Capital Expenditures | -31,000USD | -2,597,000USD | -4,593,000USD | -686,000USD | -864,000USD | -1,364,000USD | -1,810,000USD | -1,429,000USD |
| Free Cash Flow | -129,825,000USD | -197,006,000USD | -197,902,000USD | -115,987,000USD | -81,187,000USD | -49,332,000USD | -33,889,000USD | -24,521,000USD |
| Total Cashflows From Investing Activities | -28,000USD | -2,597,000USD | -4,593,000USD | -686,000USD | -809,000USD | -1,364,000USD | -1,810,000USD | -1,429,000USD |
| Net Borrowings | 99,965,000USD | 0USD | — | — | — | — | — | — |
| Total Cash From Financing Activities | 101,446,000USD | 71,678,000USD | 201,961,000USD | 258,551,000USD | 83,769,000USD | 166,456,000USD | 43,326,000USD | 13,154,000USD |
| Change In Cash | -28,376,000USD | -125,328,000USD | 4,059,000USD | 142,564,000USD | 2,637,000USD | 117,124,000USD | 9,437,000USD | -11,367,000USD |
| Begin Period Cash Flow | 152,596,000USD | 277,924,000USD | 273,865,000USD | 131,301,000USD | 128,664,000USD | 11,540,000USD | 2,103,000USD | 13,470,000USD |
| End Period Cash Flow | 124,220,000USD | 152,596,000USD | 277,924,000USD | 273,865,000USD | 131,301,000USD | 128,664,000USD | 11,540,000USD | 2,103,000USD |
| Unclassified Financing Cash Flow | 1,481,000USD | — | -200,000,000USD | 129,738,000USD | — | — | — | — |
| Investments | — | -2,597,000USD | -4,593,000USD | -686,000USD | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | 200,000,000USD | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | 71,678,000USD | 201,961,000USD | 128,813,000USD | 83,769,000USD | 166,456,000USD | 43,326,000USD | 13,982,000USD |
| Unclassified Investing Cash Flow | — | 2,597,000USD | 4,593,000USD | — | — | — | — | — |
| Change To Inventory | — | — | — | — | -11,033,000USD | 7,756,000USD | -2,471,000USD | -672,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | 55,000USD | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | -2,140,000USD | 1,085,000USD | — |
| Dividends Paid | — | — | — | — | — | — | — | -828,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2020Yearly · 2020-12-31 | Product | Grant | 80,000 | USD | 0001739614-21-000047 |
| FY 2020Yearly · 2020-12-31 | Product | License Affiliate PDL1And41BBLicense Agreement | 0 | USD | 0001739614-21-000047 |
| FY 2020Yearly · 2020-12-31 | Product | License Non Affiliate | 10,808,000 | USD | 0001739614-21-000047 |
| FY 2020Yearly · 2020-12-31 | Product | Other | 2,000,000 | USD | 0001739614-21-000047 |
| Q3 2020Quarterly · 2020-09-30 | Product | Grant | 75,000 | USD | 0001739614-21-000110 |
| Q3 2020Quarterly · 2020-09-30 | Product | License Affiliate | 2,000,000 | USD | 0001739614-21-000110 |
| Q3 2020Quarterly · 2020-09-30 | Product | License Non Affiliate | 3,826,000 | USD | 0001739614-21-000110 |
| FY 2019Yearly · 2019-12-31 | Product | Grant | 4,118,000 | USD | 0001739614-21-000047 |
| FY 2019Yearly · 2019-12-31 | Product | License Affiliate | 1,000,000 | USD | 0001739614-21-000047 |
| FY 2019Yearly · 2019-12-31 | Product | License Affiliate OX40License Agreement | 0 | USD | 0001739614-21-000047 |
| FY 2019Yearly · 2019-12-31 | Product | License Affiliate PDL1And41BBLicense Agreement | 0 | USD | 0001739614-21-000047 |
| FY 2019Yearly · 2019-12-31 | Product | License Non Affiliate | 8,093,000 | USD | 0001739614-21-000047 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.